Clinical Performance of the Diassess Influenza A and B Test

Completed · Not applicable

Conditions studied: Influenza, Human, Influenza, Flu

In brief

The primary objective of this study is device feasibility of the Diassess Influenza A and B Test

Key facts

Study ID

NCT03035396

Run by

Diassess Inc.

People needed

567

Starts

2016-12-29

Expected to finish

2017-05-01

Last updated by the study team

2018-02-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject currently has a fever (≥37.8°C/100°F), or self-reports having had or is currently treating a fever ≥37.8°C/100°F with onset within the previous 72 hrs
• Subject has at least one additional flu-like symptom including fever or feeling feverish/chills, runny or stuffy nose, muscle or body aches, fatigue (very tired), sore throat, headaches, or cough

You may not qualify if…

• Subject received nasal vaccine (e.g. FluMist) within the past 10 days
• Subject has been taking or took any antivirals for influenza in the past 30 days
• Subject enrolled in any drug trials

Where it is running

• University Health Care Center — Syracuse, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.